| Clinical Study of IM96 CAR-T Cell Therapy in Patients With Advanced Adenocarcinoma of Gastric/Esophagogastric Junction (NCT07406984) | Beijing Immunochina Medical Science & Technology Co., Ltd. | 2026-03-05 |
| Clinical Study Evaluating the Safety and Efficacy of IC19 CAR-T Cell Therapy for Refractory Systemic Lupus Erythematosus (NCT06886919) | Beijing Immunochina Medical Science & Technology Co., Ltd. | 2025-03-31 |
| Clinical Study of ZM001 Injection in the Treatment of Refractory Systemic Lupus Erythematosus (NCT06852573) | Beijing Immunochina Medical Science & Technology Co., Ltd. | 2025-02-20 |
| Clinical Study of IM96 CAR-T Cell Therapy in Patients With Advanced Colorectal Cancer (NCT06718738) | Beijing Immunochina Medical Science & Technology Co., Ltd. | 2024-12-15 |
| IM19 CAR-T Cell Therapy for IgA Nephropathy Patients and Membranous Nephropathy Patients (NCT06690359) | Beijing Immunochina Medical Science & Technology Co., Ltd. | 2024-12-13 |
| WL276 CAR-T Cell Therapy for CD276 Positive Recurrent or Progressive Glioblastoma Patients (NCT06691308) | Beijing Immunochina Medical Science & Technology Co., Ltd. | 2024-11-12 |
| IM83 Clinical Study of CAR-T Cell Therapy in Patients With Relapsed or Refractory Osteosarcoma (NCT06412458) | Beijing Immunochina Medical Science & Technology Co., Ltd. | 2024-06-15 |
| INS19 CAR-T Cells for the Treatment of Relapsed or Refractory Acute B Lymphoblastic Leukemia (NCT06209671) | Beijing Immunochina Medical Science & Technology Co., Ltd. | 2024-01-15 |
| Clinical Trial to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) B-cell Acute Lymphoblastic Leukemia (NCT05480501) | Beijing Immunochina Medical Science & Technology Co., Ltd. | 2022-07-11 |
| Clinical Trial to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) B-cell Acute Lymphoblastic Leukemia (NCT05309213) | Beijing Immunochina Medical Science & Technology Co., Ltd. | 2022-04-01 |
| Clinical Trial to Evaluate the Safety and Efficacy of IM96 CAR-T Cells Therapy in Patients With Advanced Digestive System Neoplasms (NCT05287165) | Beijing Immunochina Medical Science & Technology Co., Ltd. | 2022-03-10 |
| Clinical Trial to Evaluate the Safety and Efficacy of IM92 CAR-T Cells Therapy in Patients With Advanced Gastric or Pancreatic Adenocarcinoma (NCT05275062) | Beijing Immunochina Medical Science & Technology Co., Ltd. | 2022-02-15 |
| Safety and Efficacy of Chimeric Antigen Receptor T Lymphocytes for Patients With Intermediate and Advanced Tumors (NCT05117138) | Beijing Immunochina Medical Science & Technology Co., Ltd. | 2022-01-01 |
| Study to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) Mantle Cell Lymphoma (NCT05155215) | Beijing Immunochina Medical Science & Technology Co., Ltd. | 2021-12-31 |
| Safety and Efficacy Evaluation of IM83 CAR-T Cells for Patients With Advanced Liver Tumors (NCT05123209) | Beijing Immunochina Medical Science & Technology Co., Ltd. | 2021-08-24 |
| Donor-derived CAR-T Cells in the Treatment of AML Patients (NCT04766840) | Beijing Immunochina Medical Science & Technology Co., Ltd. | 2021-03-01 |
| Clinical Study to Evaluate the Safety and Efficacy of IM21 CAR-T Cells in the Treatment of Elderly Patients With Relapsed or Refractory Multiple Myeloma (NCT04537442) | Beijing Immunochina Medical Science & Technology Co., Ltd. | 2020-09-03 |
| Assessment of Safety and Efficacy of IM19 for Recurrent or Refractory (R/R) Non-Hodgkin's Lymphoma(NHL) Patients (NCT04440436) | Beijing Immunochina Medical Science & Technology Co., Ltd. | 2020-06-04 |
| Clinical Study of Intratumoral Injection of CAR-T Cells in the Treatment of Advanced Liver Tumors (NCT04951141) | Beijing Immunochina Medical Science & Technology Co., Ltd. | 2019-01-01 |
| Efficacy and Safety Evaluation of IM19 CAR-T Cell Therapy for MRD+ After Transplantation (NCT04336501) | Beijing Immunochina Medical Science & Technology Co., Ltd. | 2019-01-01 |
| Safety and Efficacy Evaluation of IM23 CAR-T Cells (IM23CAR-T) (NCT03585517) | Beijing Immunochina Medical Science & Technology Co., Ltd. | 2018-07-21 |
| Assessment of Safety and Efficacy of IM19 for Relapsed or Refractory NHL Patients (NCT03528421) | Beijing Immunochina Medical Science & Technology Co., Ltd. | 2018-05-22 |
| Safety and Efficacy Evaluation of Decitabine With R-GDP (NCT03535753) | Beijing Immunochina Medical Science & Technology Co., Ltd. | 2017-09-01 |